The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
CD69: from activation marker to metabolic gatekeeper
Open accessAbstract
CD69 is a membrane‐bound, type II C‐lectin receptor. It is a classical early marker of lymphocyte activation due to its rapid appearance on the surface of the plasma membrane after stimulation. CD69 is expressed by several subsets of tissue resident immune cells, including resident memory T (TRM) cells and gamma delta (γδ) T cells, and is therefore considered a marker of tissue retention. Recent evidence has revealed that CD69 regulates some specific functions of selected T‐cell subsets, determining the migration‐retention ratio as well as the acquisition of effector or regulatory phenotypes. Specifically, CD69 regulates the differentiation of regulatory T (Treg) cells as well as the secretion of IFN‐γ, IL‐17, and IL‐22. The identification of putative CD69 ligands, such as Galectin‐1 (Gal‐1), suggests that CD69‐induced signaling can be regulated not only during cognate contacts between T cells and antigen‐presenting cells in lymphoid organs, but also in the periphery, where cytokines and other metabolites control the final outcome of the immune response. Here, we will discuss new aspects of the molecular signaling mediated by CD69 and its involvement in the metabolic reprogramming regulating TH‐effector lineages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CD69 is an activation marker expressed by both effector T cells and tissue-resident (TRM) memory cells [37].”
From The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin (2025) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
Mackay, L. K., Rahimpour, A., Ma, J. Z., Collins, N., Stock, A. T., Hafon, M.-L., Vega-Ramos, J., Lauzurica, P., Mueller, S. N., Stefanovic, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2744 · Cited by 1,331
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Macintyre, A. N., Gerriets, V. A., Nichols, A., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,169
Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P. M., & Cantrell, D. A. (2013) · Nature Immunology · doi:10.1038/ni.2556 · Cited by 930
Nakaya, M., Xiao, Y., Zhou, X., Chang, J., Chang, M., Cheng, X., Blonska, M., Lin, X., & Sun, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.007 · Cited by 902
Carr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., & Frauwirth, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903586 · Cited by 830
Skon, C. N., Lee, J.-Y., Anderson, K. G., Masopust, D., Hogquist, K. A., & Jameson, S. C. (2013) · Nature Immunology · doi:10.1038/ni.2745 · Cited by 817
The outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1172/JCI200319112 · DOI
- Sanchez‐Diaz R., 2017, Thymus‐derived Treg cell development is regulated by C‐type‐lectin‐mediated BIC/miRNA155 expression, Mol. Cell Biol., 31
Cited by
Sorted by citations
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.001 · Cited by 1,461
Human T cell development, localization, and function throughout life
Kumar, B. V., Connors, T. J., & Farber, D. L. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.007 · Cited by 1,257
C-type lectins in immunity and homeostasis
Brown, G. D., Willment, J. A., & Whitehead, L. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0004-8 · Cited by 609
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Garg, A. D., More, S., Rufo, N., Meçe, O., Sassano, M. L., Agostinis, P., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1386829 · Cited by 288
Host-Directed Antiviral Therapy
Kumar, N., Sharma, S., Kumar, R., Tripathi, B. N., Barua, S., Ly, H., & Rouse, B. T. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00168-19 · Cited by 289
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
Shiao, S. L., Kershaw, K. M., Limon, J. J., You, S., Yoon, J., Ko, E. Y., Guarnerio, J., Potdar, A. A., McGovern, D. P. B., Bose, S., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.002 · Cited by 283
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Vanmeerbeek, I., Sprooten, J., Ruysscher, D. D., Tejpar, S., Vandenberghe, P., Fucikova, J. P., Špíšek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1703449 · Cited by 231
Fares, J., Ahmed, A. U., Ulasov, I. V., Sonabend, A. M., Miska, J. M., Lee-Chang, C., Balyasnikova, I. V., Chandler, J. P., Portnow, J., Tate, M. C., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00245-x · Cited by 223
Metabolic Pathways That Control Skin Homeostasis and Inflammation
Cibrián, D., de la Fuente, H., & Sánchez‐Madrid, F. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.04.004 · Cited by 216
Self-citationTissue‐resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance
Gebhardt, T., Palendira, U., Tscharke, D. C., & Bedoui, S. (2018) · Immunological Reviews · doi:10.1111/imr.12650 · Cited by 208
Tissue-Resident Memory T Cells in Cancer Immunosurveillance
Park, S. L., Gebhardt, T., & Mackay, L. K. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.002 · Cited by 197
Distinct molecular profiles of skull bone marrow in health and neurological disorders
Kolabas, Z. I., Kuemmerle, L. B., Perneczky, R., Förstera, B., Ulukaya, S., Ali, M., Kapoor, S., Bartos, L. M., Büttner, M., Çalışkan, Ö. Ş., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.009 · Cited by 196
Walsh, D., da Silva, H. B., Beura, L. K., Peng, C., Hamilton, S. E., Masopust, D., & Jameson, S. C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900052 · Cited by 174
Xu, K., Wang, R., Xie, H., Hu, L., Wang, C., Xu, J., Zhu, C., Liu, Y., Gao, F., Li, X., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00355-6 · Cited by 166
ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
Li, D.-Y., & Xiong, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02104 · Cited by 157
Liu, H., Lei, W., Zhang, C., Yang, C., Wei, J., Guo, Q., Guo, X., Chen, Z., Lu, Y., Young, K. H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1457 · Cited by 147
Transcriptomic and clonal characterization of T cells in the human central nervous system
Pappalardo, J. L., Zhang, L., Pecsok, M. K., Perlman, K., Zografou, C., Raddassi, K., Abulaban, A. A., Krishnaswamy, S., Antel, J. P., van Dijk, D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb8786 · Cited by 134
Wierz, M., Pierson, S., Guyonnet, L., Viry, E., Lequeux, A., Oudin, A., Niclou, S. P., Ollert, M. W., Berchem, G., Janji, B., et al. (2018) · Blood · doi:10.1182/blood-2017-06-792267 · Cited by 137
Human NK cells: From development to effector functions
Arachchige, A. S. P. M. (2020) · Innate Immunity · doi:10.1177/17534259211001512 · Cited by 149
A unified atlas of CD8 T cell dysfunctional states in cancer and infection
Pritykin, Y., van der Veeken, J., Pine, A. R., Zhong, Y., Şahin, M., Mažutis, L., Pe’er, D., Rudensky, A. Y., & Leslie, C. S. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.045 · Cited by 117
Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis
Beltrán, E., Gerdes, L. A., Hansen, J., Flierl‐Hecht, A., Krebs, S., Blum, H., Ertl-Wagner, B. B., Barkhof, F., Kümpfel, T., Hohlfeld, R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128475 · Cited by 130
Ogongo, P., Tezera, L. B., Ardain, A., Nhamoyebonde, S., Ramsuran, D., Singh, A., Ngoepe, A., Karim, F., Naidoo, T., Khan, K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142014 · Cited by 120
Logun, M. T., Wang, X., Sun, Y. Y., Bagley, S. J., Li, N., Desai, A. S., Zhang, D. Y., Nasrallah, M. P., Pai, E. L.-L., Oner, B. S., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.11.010 · Cited by 127
Yu, L., Yang, F., Zhang, F., Guo, D., Li, L., Wang, X., Liang, T., Wang, J., Cai, Z., & Jin, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0927-9 · Cited by 117
Pompura, S. L., Wagner, A., Kitz, A., Laperche, J. M., Yosef, N., Dominguez‐Villar, M., & Hafler, D. A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138519 · Cited by 121
The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog
Long, H. M., Meckiff, B. J., & Taylor, G. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02193 · Cited by 110
Lucas, C. R., Halley, P. D., Chowdury, A. A., Harrington, B. K., Beaver, L. P., Lapalombella, R., Johnson, A. J., Hertlein, E. K., Phelps, M. A., Byrd, J. C., et al. (2022) · Small · doi:10.1002/smll.202108063 · Cited by 108
Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy
Harding, D., Chong, M. H. A., Lahoti, N., Bigogno, C. M., Prema, R., MOHIDDIN, S. A., & Marelli‐Berg, F. M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13556 · Cited by 109
The immune cell atlas of human neuroblastoma
Verhoeven, B. M., Mei, S., Olsen, T. K., Gustafsson, K. U., Valind, A., Lindström, A., Gisselsson, D., Fard, S. S., Hagerling, C., Kharchenko, P. V., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100657 · Cited by 100
Depuydt, M. A. C., Schaftenaar, F. H., Prange, K. H. M., Boltjes, A., Hemme, E., Delfos, L., de Mol, J., de Jong, M. J. M., Kleijn, M. N. A. B., Peeters, J. A. H. M., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00208-4 · Cited by 105
Eskandari, S. K., Sulkaj, I., Melo, M. B., Li, N., Allos, H., Alhaddad, J. B., Kollár, B., Borges, T. J., Eskandari, A. S., Zinter, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw4744 · Cited by 97
Sengupta, S., Das, S., Crespo, Â. C., Cornel, A. M., Patel, A. G., Mahadevan, N. R., Campisi, M., Ali, A. K., Sharma, B., Rowe, J. H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00427-5 · Cited by 101
Modulation of immunity by tryptophan microbial metabolites
Li, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209613 · Cited by 104
Control of Immunoregulatory Molecules by miRNAs in T Cell Activation
Rodríguez‐Galán, A., Fernández‐Messina, L., & Sánchez‐Madrid, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02148 · Cited by 88
Self-citationMcEvoy, C. M., Murphy, J. M., Zhang, L., Clotet‐Freixas, S., Mathews, J. A., An, J., Karimzadeh, M., Pouyabahar, D., Su, S., Zaslaver, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35297-z · Cited by 93
The pivotal role of CD69 in autoimmunity
Gorabi, A. M., Hajighasemi, S., Kiaie, N., Hayat, S. M. G., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102453 · Cited by 88
Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse?
Steinbach, K., Vincenti, I., & Merkler, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02827 · Cited by 90
Tissue-Resident Lymphocytes in the Kidney
Turner, J., Becker, M., Mittrücker, H., & Panzer, U. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017060599 · Cited by 89
Chen, J., Liu, K., Luo, Y., Kang, M., Wang, J., Chen, G., Qi, J., Wu, W., Wang, B., Han, Y., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.008 · Cited by 84
Seo, W., Shimizu, K., Kojo, S., Okeke, A., Kohwi-shigematsu, T., Fujii, S., & Taniuchi, I. (2020) · Nature Communications · doi:10.1038/s41467-020-15375-w · Cited by 85
Teixeira, P. C., Dorneles, G. P., Filho, P. S., da Silva, I. M., Schipper, L. L., Postiga, I. A. L., Neves, C. A. M., Rodrigues, L. C., Peres, A., de Souto, J. T., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108125 · Cited by 83
Goldberg, M. F., Roeske, E., Ward, L. N., Pengo, T., Dileepan, T., Kotov, D. I., & Jenkins, M. K. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.009 · Cited by 81
Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis
Ogongo, P., Porterfield, J. Z., & Leslie, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00992 · Cited by 84
He, C., Zhou, Y. Y., Li, Z., Farooq, M. A., Ajmal, I., Zhang, H., Zhang, L., Tao, L., Yao, J., Du, B., et al. (2020) · Cancers · doi:10.3390/cancers12071969 · Cited by 82
Monocyte-derived S1P in the lymph node regulates immune responses
Baeyens, A., Bracero, S., Chaluvadi, V. S., Khodadadi‐Jamayran, A., Cammer, M., & Schwab, S. R. (2021) · Nature · doi:10.1038/s41586-021-03227-6 · Cited by 82
Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation
Strobl, J., Gail, L. M., Kleißl, L., Pandey, R. V., Smejkal, V., Huber, J., Puxkandl, V., Unterluggauer, L., Dingelmaier‐Hovorka, R., Atzmüller, D., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210417 · Cited by 80
Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies
Kroll, K. T., Mata, M. M., Homan, K. A., Micallef, V., Carpy, A., Hiratsuka, K., Morizane, R., Moisan, A., Gubler, M., Walz, A.-C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305322120 · Cited by 79
Schwarz, A., Philippsen, R., & Schwarz, T. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.04.031 · Cited by 87
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells
Leite, N. C., Sintov, E., Meissner, T. B., Brehm, M. A., Greiner, D. L., Harlan, D. M., & Melton, D. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107894 · Cited by 78
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy
Metzloff, A. E., Padilla, M. S., Gong, N., Billingsley, M. M., Han, X., Merolle, M. I., Mai, D., Figueroa‐Espada, C. G., Thatte, A. S., Haley, R. M., et al. (2024) · Advanced Materials · doi:10.1002/adma.202313226 · Cited by 82
Mias, C., Mengeaud, V., Bessou‐Touya, S., & Duplan, H. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18794 · Cited by 88
Zhou, Y., Xie, L., Schröder, J., Schuster, I. S., Nakai, M. E., Sun, G., Sun, Y., Mariño, E., Degli‐Esposti, M. A., Marques, F. Z., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0724-23.2023 · Cited by 80
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 75
Dai, M., Hong, L., Yin, T., & Liu, S. (2024) · Endocrinology · doi:10.1210/endocr/bqae023 · Cited by 72
Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
Arnone, M., Konantz, M., Hanns, P., Stanger, A. M. P., Bertels, S., Godavarthy, P. S., Christopeit, M., & Lengerke, C. (2020) · Cancers · doi:10.3390/cancers12123742 · Cited by 70
Knitz, M. W., Bickett, T. E., Darragh, L. B., Oweida, A. J., Bhatia, S., Court, B. V., Bhuvane, S., Piper, M., Gadwa, J., Mueller, A. C., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001955 · Cited by 71
Cai, F., Li, S., Huang, H. S., Iqbal, J., Wang, C., & Jiang, X. (2021) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37281 · Cited by 73
An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression
Wang, L., Li, G., Cao, L., Dong, Y., Wang, Y., Wang, S., Li, Y., Guo, X., Zhang, Y., Sun, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj4796 · Cited by 69
CD28 and CD57 define four populations with distinct phenotypic properties within human CD8+ T cells
Pangrazzi, L., Reidla, J., Arana, J. A. C., Naismith, E., Miggitsch, C., Meryk, A., Keller, M., Krause, A. A. N., Melzer, F. L., Trieb, K., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948362 · Cited by 65
Effect of melatonin on T/B cell activation and immune regulation in pinealectomy mice
Luo, J., Zhang, Z., Sun, H., Song, J. H., Chen, X., Huang, J., Lin, X., & Zhou, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117191 · Cited by 68
Human mucosal tissue-resident memory T cells in health and disease
Lange, J., Rivera‐Ballesteros, O., & Buggert, M. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00467-7 · Cited by 72
Sachs, K., Sarver, A. L., Noble-Orcutt, K. E., LaRue, R. S., Antony, M. L., Chang, D., Lee, Y., Navis, C. M., Hillesheim, A. L., Nykaza, I. R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2932 · Cited by 69
Boustany, L. M., LaPorte, S. L., Wong, L., White, C. W., Vinod, V., Shen, J., Yu, W., Koditek, D., Winter, M. B., Moore, S. J., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2483 · Cited by 67
Li, L., Tang, W., Zhang, Y., Jia, M., Wang, L., Li, Q., Han, Q., Peng, X., Xie, Y., Wu, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.024 · Cited by 65
CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma
Gauthier, M. C., Kale, S. L., Oriss, T. B., Gorry, M. C., Ramonell, R. P., Dalton, K., Ray, P., Fahy, J. V., Seibold, M. A., Castro, M., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.02.028 · Cited by 63
Proïcs, E., David, M., Mojibian, M., Speck, M., Lounnas-Mourey, N., Govehovitch, A., Baghdadi, W., Desnouveaux, J., Bastian, H., Freschi, L., et al. (2022) · Gene Therapy · doi:10.1038/s41434-022-00358-x · Cited by 62
Kovacs, K. G., Mácsik‐Valent, B., Matkó, J., Bajtay, Z., & Erdei, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620427 · Cited by 59
Bruni, E., Cimino, M., Donadon, M., Carriero, R., Terzoli, S., Piazza, R., Ravens, S., Prinz, I., Cazzetta, V., Marzano, P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004579 · Cited by 59
Xydia, M., Rahbari, R., Ruggiero, E., Macaulay, I. C., Tarabichi, M., Lohmayer, R., Wilkening, S., Michels, T., Brown, D. V., Vanuytven, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21297-y · Cited by 59
Jensen, G. S., Cash, H. A., Farmer, S., & Keller, D. (2017) · Journal of Inflammation Research · doi:10.2147/jir.s141660 · Cited by 59
Song, P., Li, W., Wu, X., Qian, Z., Ying, J., Gao, S., & He, J. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03143-2 · Cited by 54
Brown, B., Ojha, V., Fricke, I., Al-Sheboul, S. A., Imarogbe, C., Gravier, T., Green, M., Peterson, L., Koutsaroff, I. P., Demir, A. N., et al. (2023) · Vaccines · doi:10.3390/vaccines11020408 · Cited by 55
T cells in cardiac health and disease
Martín, P., & Sánchez‐Madrid, F. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185218 · Cited by 58
Self-citationPéterfalvi, Á., Meggyes, M., Makszin, L., Farkas, N., Mikó, É., Miseta, A., & Szereday, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18042067 · Cited by 61
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
Li, Y., Gu, Y., Yang, P., Wang, Y., Yu, X., Li, Y., Jin, Z., & Xu, L. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s439969 · Cited by 54
Strasser, K., Birnleitner, H., Beer, A., Pils, D., Gerner, M. C., Schmetterer, K. G., Bachleitner‐Hofmann, T., Stift, A., Bergmann, M. M., & Oehler, R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1537693 · Cited by 54
Roosenboom, B., Wahab, P. J., Smids, C., Groenen, M. J. M., van Koolwijk, E., van Lochem, E. G., & Horje, C. S. H. T. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz049 · Cited by 51
Podestà, M. A., Binder, C., Sellberg, F., DeWolf, S., Shonts, B. A., Ho, S., Obradović, A., Waffarn, E., Danzl, N. M., Berglund, D., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15533 · Cited by 51
Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
Wang, T., Shen, Y., Luyten, S., Yang, Y., & Jiang, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104876 · Cited by 53
A CAR enhancer increases the activity and persistence of CAR T cells
Rakhshandehroo, T., Mantri, S. R., Moravej, S. H., Louis, B. B. V., Farid, A. S., Munaretto, L., Regan, K., Khan, R. M. M., Wolff, A. N., Farkash, Z., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02339-4 · Cited by 55
Zhou, Q., Ding, W., Qian, Z., Zhu, Q., Sun, C., Qin, Y., Tai, Z., & Ke Cheng, X. U. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00448 · Cited by 53
Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver
Shen, S., Dai, H., Fei, Z., Chai, Y., Hao, Y., Fan, Q., Dong, Z., Zhu, Y., Xu, J., Ma, Q., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c02391 · Cited by 52
Comeau, K., Paradis, P., & Schiffrin, E. L. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104217 · Cited by 53
Guo, Y., Li, Y., Cai, B., He, Q., Chen, G., Wang, M., Wang, K., Wan, X., & Yan, Q. (2021) · Aging · doi:10.18632/aging.202288 · Cited by 51
Mills, T., Kain, B. N., Burchill, M. A., Danis, E. P., Lucas, E. D., Culp‐Hill, R., Cowan, C. M., Schleicher, W. E., Patel, S. B., Tran, B. T., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.010 · Cited by 52
Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer
Beccard, I. J., Hofmann, L., Schroeder, J. C., Ludwig, S., Laban, S. A., Brunner, C., Lotfi, R., Hoffmann, T. K., Jackson, E. K., Schuler, P. J., et al. (2020) · Cancers · doi:10.3390/cancers12071997 · Cited by 49
Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis
Patel, J., Maddukuri, S., Li, Y., Bax, C. E., & Werth, V. P. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.748 · Cited by 48
Tan, J., Taitz, J., Sun, S. M., Langford, L., Ni, D., & Macia, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.878382 · Cited by 50
Phu, T. A., Ng, M., Vu, N. K., Gao, A. S., & Raffaï, R. L. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12345 · Cited by 54
Effects of aflatoxin on the immune system: Evidence from human and mammalian animal research
Turna, N. S., Comstock, S. S., Gangur, V., & Wu, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2219336 · Cited by 47
Houerbi, N., Kim, J., Overbey, E. G., Batra, R., Schweickart, A., Pătraș, L., Lucotti, S., Ryon, K. A., Najjar, D., Meydan, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48841-w · Cited by 48
Yun, Y., Kanda, A., Kobayashi, Y., Bui, D. V., Suzuki, K., Sawada, S., Baba, K., Yagi, M., Asako, M., Okazaki, H., et al. (2020) · Allergology International · doi:10.1016/j.alit.2019.11.002 · Cited by 47
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma
Rossi, M., Altomare, E., Botta, C., Cantafio, M. E. G., Sarvide, S., Caracciolo, D., Riillo, C., Gaspari, M., Taverna, D., Conforti, F. S., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0947-1 · Cited by 48
Accumulation of γδ T cells in visceral fat with aging promotes chronic inflammation
Bruno, M. E. C., Mukherjee, S., Powell, W. L., Mori, S. F., Wallace, F. K., Balasuriya, B. K., Su, L. C., Stromberg, A. J., Cohen, D. A., & Starr, M. E. (2022) · GeroScience · doi:10.1007/s11357-022-00572-w · Cited by 47
Qin, L., Cui, Y., Yuan, T., Chen, D., Zhao, R., Li, S., Jiang, Z., Wu, Q., Long, Y., Wang, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33793-w · Cited by 47
Helicase-assisted continuous editing for programmable mutagenesis of endogenous genomes
Chen, X. D., Chen, Z., Wythes, G., Zhang, Y., Orr, B. C., Sun, G., Chao, Y.-K., Torres, A. N., Thao, K., Vallurupalli, M., et al. (2024) · Science · doi:10.1126/science.adn5876 · Cited by 47
Wang, S., Zhao, Y., Wang, G., Feng, S., Guo, Z., & Gu, G. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00347 · Cited by 45
Yang, Q., Zhang, M., Chen, Q., Chen, W., Wei, C., Qiao, K., Ye, T., Deng, G., Li, J., Zhu, J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901326 · Cited by 45
Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
Hong, L., Alu, A., Yang, H. J., He, C., Hong, W., Cheng, Z., Yang, L., Li, J., Wang, Z., Wang, W., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00434-x · Cited by 45
Human T lymphocytes at tumor sites
Notarbartolo, S., & Abrignani, S. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00970-4 · Cited by 49
Metadata
- Authors
- Cibrián, D., & Sánchez‐Madrid, F.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Sánchez‐Madrid, Francisco
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2017-06
- Volume
- 47
- Issue
- 6
- Pages
- 946-953
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC6485631
- OpenAlex
- W2610932550
- Cited by
- 948
- References
- 63
- Citations by year
- 2026: 109 · 2025: 175 · 2024: 150 · 2023: 132 · 2022: 134 · 2021: 101 · 2020: 77 · 2019: 44 · 2018: 22 · 2017: 4
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Instituto de Salud Carlos III
- Federación Española de Enfermedades Raras
- European Research Council (ERC‐2011‐AdG294340‐GENTRIS)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- CD69, lymphocyte activation, tissue-resident memory T cells, γδ T cells, Treg differentiation, galectin-1, T cell metabolism, metabolic reprogramming, cytokine production, T cell signaling
- MeSH terms
- CD69 Antigens, Animals, Antigen-Presenting Cells, Antigens, Differentiation, T-Lymphocyte, Cell Differentiation, Gene Expression Regulation, Humans, Lymphocyte Activation, Signal Transduction, Antigens, CD, T-Lymphocyte Subsets, Cytokines, Interleukin-17, Galectins, Lectins, C-Type, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review